Evidence map›Paper›PMID 38734683›Full record

ArticleNPJ microgravity2024

Development of a kidney microphysiological system hardware platform for microgravity studies.

Kendan A Jones-Isaac, Kevin A Lidberg, Catherine K Yeung, Jade Yang, Jacelyn Bain, Micaela Ruiz, Greta Koenig, Paul Koenig, Stefanie Countryman, Jonathan Himmelfarb and 1 more

Abstract read
In one paragraph

Article in NPJ microgravity, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Heart-on-a-Chip at the final frontier.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Kendan A Jones-IsaacDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Kevin A LidbergDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Catherine K YeungDepartment of Pharmacy, University of Washington, Seattle, WA, USA. cathyy@uw.edu.ORCID http://orcid.org/0000-0002-6556-6641
Jade YangDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0009-0009-3195-218X
Jacelyn BainDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.
Micaela RuizDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-3707-5589
Greta KoenigBioServe Space Technologies, University of Colorado, Boulder, CO, USA.
Paul KoenigBioServe Space Technologies, University of Colorado, Boulder, CO, USA.
Stefanie CountrymanBioServe Space Technologies, University of Colorado, Boulder, CO, USA.
Jonathan HimmelfarbKidney Research Institute, Seattle, WA, USA.
Edward J KellyDepartment of Pharmaceutics, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-6534-9313

Funding

XENOBIOTIC BIOTRANSFORMATION AND DISPOSITIONP30ES007033 · NIEHS · UNIVERSITY OF WASHINGTON · PI Nicole Ann Errett · 1995 to 2026
$42.5M
Using iPSCs to model patient outcomes in nephrotic syndromeUH3TR000504 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2014 to 2016
$6.1M
A Microphysiological System for Kidney Disease Modeling and Drug Efficacy TestingUG3TR002158 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN · 2017 to 2018
$2.9M
Effects of microgravity on the structure and function of proximal and distal tubule MPSUH3TR002178 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, KELLY, EDWARD J · 2019 to 2020
$842k
Effects of microgravity on the structure and function of proximal and distal tubule MPSUG3TR002178 · NCATS · UNIVERSITY OF WASHINGTON · PI HIMMELFARB, JONATHAN, KELLY, EDWARD J · 2017 to 2018
$769k
NCATS NIH HHS UG3 TR002158NCATS NIH HHS UG3 TR002178NCATS NIH HHS UH3 TR000504NCATS NIH HHS UH3 TR002178NIEHS NIH HHS P30 ES007033
6 · The paper itself

Abstract

Determining the physiological effects of microgravity on the human kidney is limited to relatively insensitive tests of biofluids (blood and urine) that do not return abnormal results until more than 50% of kidney function is lost. We have developed an "organ on chip" microphysiological model of the human kidney proximal tubule (PT-MPS) that can recapitulate many kidney functions and disease states and could play a critical role in determining mechanisms of early kidney dysfunction in microgravity. However, the ground-based PT-MPS system is incompatible with spaceflight as it requires a large pneumatic system coupled to a cell incubator for perfusion and intensive hand-on manipulation. Herein, we report the hardware engineering and performance of the Kidney Chip Perfusion Platform (KCPP), a small, advanced, semi-autonomous hardware platform to support kidney microphysiological model experiments in microgravity. The KCPP is composed of five components, the kidney MPS, the MPS housing and valve block, media cassettes, fixative cassettes, and the programable precision syringe pump. The system has been deployed twice to the ISSNL (aboard CRS-17 and CRS-22). From each set of ISSNL experiments and ground-based controls, we were able to recover PT-MPS effluent for biomarker analysis and RNA suitable for transcriptomics analysis demonstrating the usability and functionality of the KCPP.

Identifiers

PMID38734683
PMCPMC11088639

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.